MPM BioImpact’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-323,813
| Closed | -$1.38M | – | 40 |
|
|
2023
Q4 | $1.38M | Sell |
323,813
-3,108
| -1% | -$13.2K | 0.32% | 31 |
|
|
2023
Q3 | $1.37M | Hold |
326,921
| – | – | 0.37% | 31 |
|
|
2023
Q2 | $1.82M | Buy |
326,921
+93,193
| +40% | +$519K | 0.37% | 32 |
|
|
2023
Q1 | $1.34M | Buy |
233,728
+3,228
| +1% | +$18.5K | 0.35% | 28 |
|
|
2022
Q4 | $242K | Sell |
230,500
-430,644
| -65% | -$452K | 0.06% | 33 |
|
|
2022
Q3 | $1.77M | Sell |
661,144
-3,836
| -0.6% | -$10.3K | 0.42% | 34 |
|
|
2022
Q2 | $3.17M | Buy |
664,980
+370,000
| +125% | +$1.76M | 0.88% | 26 |
|
|
2022
Q1 | $1.21M | Sell |
294,980
-7,635
| -3% | -$31.2K | 0.32% | 35 |
|
|
2021
Q4 | $2.06M | Sell |
302,615
-18,109
| -6% | -$124K | 0.38% | 32 |
|
|
2021
Q3 | $3.72M | Buy |
+320,724
| New | +$3.72M | 0.58% | 31 |
|